Skip to content


Drug development at the speed of AI

X‑37 aims to use AI to accelerate small-molecule drug discovery. The company’s seasoned chemists, biologists, and data scientists use machine learning algorithms to identify chemicals with drug-like structures, predict whether they might bind to biological targets, and weed out those likely to have unwanted properties.

Explore Companies